Article
TP53 p.R72P genotype is a marker of poor prognosis in lung cancer.
Cancer biomarkers : section A of Disease markers - 1 Jan 2018
Neumann Mirko Peter, González María Victoria, Pitiot Ana S, Santamaría Íñigo, Martínez Cristina, Tardón Adonina, Astudillo Aurora, Balbín Milagros
Abstract excerpt
BACKGROUND: Lung cancer is a leading cause of death worldwide, with poor survival rates despite diagnostic and therapeutic advances. Markers are needed in order to improve clinical patient management and survival. TP53 is frequently involved in lung cancer development with polymorphic sites potentially having a role in it. This study aims to determine the value of codon 72 missense polymorphic variant genotyping,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
